N

NextVivo

7 employees

NextVivo is a biotech company developing an immune organoid technology platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
drug discovery
t cells
immunotherapy
antibodies
immunology

Date founded

2021

Funding rounds raised

Total raised

$7.9M

from 2 investors over 2 rounds

N

NextVivo raised $7.9M on December 9, 2021

Investors: Wilson Sonsini Goodrich & Rosati and Khosla Ventures

FAQ